FRSHY yields 2.05% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, FRSHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FRSHY + JNJ for your $10,000?
China Jinmao Holdings Group Limited, an investment holding company, operates in real estate and hotel businesses in Mainland China. It operates in four segments: City and Property Development, Commercial Leasing and Retail Operations, Hotel Operations, and Others. The City and Property Development segment develops city complexes and properties, as well as develops land. The Commercial Leasing and Retail Operations segment engages in the leasing of office and retail commercial premises. This segment has twelve investment properties with an area of approximately 0.80 million square meters. The Hotel Operations segment provides hotel accommodation, and food and beverages services. This segment operates ten luxury hotels that offers 3,968 guest rooms. The Others segment offers property management, and design and decoration services, as well as operates an observation deck. The company also engages in technology and services business. It holds 334 projects of city operations and property development, commercial leasing and retail operations, and hotel operations. The company was formerly known as Franshion Properties (China) Limited and changed its name to China Jinmao Holdings Group Limited in September 2015. China Jinmao Holdings Group Limited was incorporated in 2004 and is based in Wan Chai, Hong Kong.
Full FRSHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.